RECRUITING
I'm interested ...!!
Enhancing Attention and Wellbeing Using Digital Therapeutics
The goals of the proposed research are to first determine the minimal and/or optimal dose of a digital intervention required for cognitive enhancement, and then to examine the impact of several potential moderators of treatment effects (i.e., cognitive decline, AD polygenic hazard score, cardiovascular risk, and race/ethnicity). This knowledge gained from his high-impact study with transform the field of cognitive interventions, paving the way for a precision medicine model for cognitive enhancing interventions that improve quality of life for older adults and individuals with cognitive deficits at risk of developing dementia.
Conditions:
🦠 Aging 🦠 MCI 🦠 Cognitive Decline
🗓️ Study Start (Actual) 1 April 2024
🗓️ Primary Completion (Estimated) June 2029
✅ Study Completion (Estimated) June 2029
👥 Enrollment (Estimated) 4000
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 San Francisco, California, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * 60+ years old (adult)
    • * English language fluency
    • * owning a smartphone or tablet

    Exclusion Criteria:

    • * Under 60 years old (minor)
Ages Eligible for Study: 60 Years to 99 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 23 April 2024
  • First Submitted that Met QC Criteria 30 April 2024
  • First Posted 3 May 2024

Study Record Updates

  • Last Update Submitted that Met QC Criteria 30 April 2024
  • Last Update Posted 3 May 2024
  • Last Verified April 2024
I'm interested ...!!